Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03687931 · ClinicalTrials.gov registry record · Phase 1
A Clinical Study to Assess the Efficacy and Safety of Dexamethasone Suspension for Cataract Surgery
A Phase 1 study of Inflammation Eye, sponsored by iDrop.
- Completed
- Registry status
- Phase 1
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT03687931 is a Phase 1 study of Inflammation Eye that has completed, run by iDrop. The registered enrollment target is 60 participants. The trial reports 1 study location across 1 state.
The verdict
NCT03687931, a Phase 1 study of Inflammation Eye, has completed, sponsored by iDrop.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
Patients at least 40 years of age who are undergoing cataract surgery will be randomized to receive treatment with one of two dose levels of dexamethasone ophthalmic suspension eye drops to determine if the drops decrease inflammation inside the eye and are safe after cataract surgery.
Conditions Studied
Interventions
- DRUG Dexamethasone
Study Locations (1)
Arizona
- Arizona Eye Center - Chandler
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2018-08-26 |
| Est. Completion | 2019-02-28 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03687931
The ClinicalTrials.gov registry entry for NCT03687931 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is iDrop, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Inflammation Eye appearing as the primary indexed condition, and to 1 intervention - of which Dexamethasone is the first listed.
NCT03687931 reports 1 study location spanning 1 distinct geographic area - top geographies include Arizona.
Frequently Asked Questions
What is clinical trial NCT03687931 about?
NCT03687931 is a clinical study titled "A Clinical Study to Assess the Efficacy and Safety of Dexamethasone Suspension for Cataract Surgery". Patients at least 40 years of age who are undergoing cataract surgery will be randomized to receive treatment with one of two dose levels of dexamethasone ophthalmic suspension eye drops to determine if the drops decrease inflammation inside the eye and are safe after cataract surgery.
What is the current status of trial NCT03687931?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 60 participants. The study started on 2018-08-26. Estimated completion is 2019-02-28.
What conditions does trial NCT03687931 study?
This clinical trial studies the following conditions: Inflammation Eye.
What interventions are being tested in trial NCT03687931?
The interventions under investigation include: Dexamethasone (DRUG).
Who is sponsoring clinical trial NCT03687931?
This trial is sponsored by iDrop, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03687931 being conducted?
This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.